
Used to diagnose acute/fresh (recent) infection with Borrelia bacteria, which causes Lyme disease and is transmitted by ticks.
Description of the blood test:
The Borrelia burgdorferi IgM antibody test is a serological study used to detect the body’s acute-phase immune response to an infection caused by Borrelia bacteria, typically transmitted through tick bites. IgM antibodies are the first to appear after infection, serving as indicators of the early stage of Lyme disease (borreliosis). Timely identification of these markers is essential for initiating early treatment and preventing the transition of the disease into a chronic form that affects the joints, heart, and nervous system.
What does the analysis represent?
Recommendations for the test (General)
What can affect the results?
When to take the test?
How to interpret the results?
The interpretation of serological data is the exclusive responsibility of an infectious disease specialist. The presence of Borrelia IgM antibodies is a biochemical indicator of an early immune response to the bacteria but is not a standalone diagnosis of borreliosis. The physician must evaluate these laboratory findings alongside the history of tick exposure, clinical symptoms, and the stage of the illness. Only an expert can confirm the diagnosis and distinguish an active infection from potential cross-reactivity with other pathogens.
Possible further investigations
When does the next step make sense?
Detecting IgM antibodies to Borrelia indicates a high probability of a recent infection that requires medical intervention. The next step is a consultation with a specialist to confirm the diagnosis and start treatment, which is highly effective in the early stages and prevents long-term health complications.
👉 If necessary, you can discuss the test results with our specialized — neurologist ( Doctors – TAMC ).